Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.

Published Date: 30 Oct 2023

The INTERLACE phase III trial, run by UCL and UCLH researchers and funded by Cancer Research UK, has made a ground-breaking discovery.

Read Full News

Latest News

Lesser-known lobular breast cancer on the rise in U.S. women

The American Cancer Society has released a report on occurrence and outcomes in the United States for this subtype of breast cancer. Findings show an estimated 33,600 women will be diagnosed with lobular breast cancer or ...

Study recommends new grading system for invasive squamous cell carcinoma of the lung

Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic options for LUSC remain limited, primarily due to the absence of well-defined, targetable molecular ...

Neural networks and label-free microscopy enable accurate detection of pancreatic tumors

Pancreatic neuroendocrine neoplasms (PNENs) are a rare form of cancer that affects hormone-producing cells in the pancreas. Although uncommon, their incidence has been rising steadily over the past few decades.

Q&A: Breast cancer facts that could save lives

October is Breast Cancer Awareness Month, a time to spotlight a disease that will affect hundreds of thousands of Americans this year. In the U.S., a new case of breast cancer is diagnosed about every two minutes, with more ...

Patients value communication skills from cancer surgeons across six key areas, according to research

Facing a cancer diagnosis can be one of the most stressful times for patients and their loved ones. When seeking a surgeon for treatment, providing emotional support and helping patients manage expectations are among the ...

Drop in credit score after cancer diagnosis linked to increased mortality

Patients with cancer whose credit scores decline after their diagnosis face a significantly higher risk of mortality, providing the first objective data linking financial health to physical survival.

Todays Updates

Exercise may help breast cancer survivors manage weight

New UBC Okanagan research shows that exercise can do more than improve the strength and cardiovascular endurance of women who have survived breast cancer.

A radiotheranostic approach designed to combat aggressive cancers

UCLA scientists, together with a team of international collaborators, have identified a promising new treatment strategy that can detect, kill and reprogram aggressive, treatment-resistant tumors like osteosarcomas and glioblastoma.

Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines

A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA cancer vaccine platform. The study introduces an immune cell homing hydrogel-based platform designed ...

Todays Updates

Exercise may help breast cancer survivors manage weight

New UBC Okanagan research shows that exercise can do more than improve the strength and cardiovascular endurance of women who have survived breast cancer.

A radiotheranostic approach designed to combat aggressive cancers

UCLA scientists, together with a team of international collaborators, have identified a promising new treatment strategy that can detect, kill and reprogram aggressive, treatment-resistant tumors like osteosarcomas and glioblastoma.

Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines

A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA cancer vaccine platform. The study introduces an immune cell homing hydrogel-based platform designed ...

Latest News

The American Cancer Society has released a report on occurrence and outcomes in the United States for this subtype of breast cancer. Findings show an estimated 33,600 women will be diagnosed with lobular breast cancer or ...

Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic options for LUSC remain limited, primarily due to the absence of well-defined, targetable molecular ...

Pancreatic neuroendocrine neoplasms (PNENs) are a rare form of cancer that affects hormone-producing cells in the pancreas. Although uncommon, their incidence has been rising steadily over the past few decades.

October is Breast Cancer Awareness Month, a time to spotlight a disease that will affect hundreds of thousands of Americans this year. In the U.S., a new case of breast cancer is diagnosed about every two minutes, with more ...

Facing a cancer diagnosis can be one of the most stressful times for patients and their loved ones. When seeking a surgeon for treatment, providing emotional support and helping patients manage expectations are among the ...

Patients with cancer whose credit scores decline after their diagnosis face a significantly higher risk of mortality, providing the first objective data linking financial health to physical survival.

News All Time

Obesity-associated cancers may be on the rise in Puerto Rico

The incidence of obesity-associated cancers in Puerto Rico rose significantly between 2000 and 2022, according to research presented at the 18th AACR Conference on the Science of Cancer Health Disparities, held September ...

Health researchers discuss Medicaid cancer screening trends, best practices

New Jersey has the 10th-highest rate of cancer incidence in the United States. It is the second leading cause of death in New Jersey, and thousands of residents die from preventable cancers each year.

Scientists identify dual protein targets to weaken pancreatic cancer defenses

Indiana University School of Medicine scientists have identified a new way to weaken pancreatic cancer's defenses by targeting two key proteins that help the deadly disease resist treatment. The study, recently published ...

Study finds 10% of pediatric blood cancers may stem from medical imaging radiation

A study led by UC San Francisco and UC Davis has concluded that radiation from medical imaging is associated with a higher risk of blood cancers in children.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

A new study, led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, captured details of glioblastoma that had never before been seen and revealed a surprise ...

Remote monitoring can improve recovery from cancer surgery

A new study co-authored by Tracy Crane, Ph.D., RDN, co-leader of the Cancer Control Program at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, shows that remote perioperative ...

Targeted radiation therapy shows near-complete response in rare sarcoma patients

A novel targeted radiation approach for a rare form of malignant tumor—the solitary fibrous tumor (SFT)—has shown significant success, achieving a near-complete response in three patients. The therapy significantly reduced ...

Algorithm that predicts pancreatic cancer metastasis could help avoid unnecessary surgeries

Pancreatic cancer remains one of the biggest challenges in the field of oncology. Numbers of cases are increasing, and the latest personalized therapies and immunotherapy are not yet yielding results. Much of the effort is ...

Basal stem-like cells identified as origin of small cell lung cancer in lab models

A new study reveals that small cell lung cancer (SCLC) likely begins in basal stem-like cells rather than in neuroendocrine cells, marking a major shift in the understanding of this aggressive disease that is often associated ...

As pesticides and wildfires rise, kids with cancer need resources

A growing body of research ties environmental pollutants to worse health and shorter life spans for childhood cancer survivors. Yet medical providers lack sufficient resources to address these risks with patients, a recent ...

Two-part prodrug system activates immune attack only in tumor's unique environment

Scientists have developed a smarter way to activate the immune system against cancer, potentially making treatments safer and more precise.

Study finds primary-care doctors often overlook prostate cancer risk in Black men

Although Black men die of prostate cancer at twice the rate of the rest of U.S. males, this fact often is not known or considered during appointments with their primary-care clinicians to discuss a common screening test.

Research exposes far-reaching toll of financial hardship on patients with cancer

When someone mentions the word "toxicity" in relation to cancer treatment, they're usually referring to the negative physical side effects and complications that can result from therapies like radiation and chemotherapy. ...

Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals

Researchers from Keele University have revealed that retired Olympic athletes are more likely to develop skin cancer and osteoarthritis than the general population.

How to keep your prostate healthy and lower your risk of developing serious problems

For something so small, the prostate can cause big problems. This gland, which is roughly the size of a walnut, is an essential part of a man's urinary and reproductive systems.

Millions of men could benefit from faster scan to diagnose prostate cancer

A quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30–40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, according to clinical trial ...

Recommended News For You

Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation

Children with cancer tumors lacking DNA repair may benefit from olaparib combined with ceralasertib.

The FDA approves alexinib as an adjuvant treatment for non-small cell lung cancer.

Radiation from CT scans could account for 5% of all cancer cases a year, study suggests

Through the activation of bitter taste receptors, lidocaine has the potential to kill some cancer cells.

New drug combination shows particularly good results in patients with HPV-negative head and neck cancer

A study has developed molecular markers that predict meningioma recurrence.

Recommended Articles For You

Interplay of Brown Hair, Follicular Biology, and Hair Growth Inhibitors in Melanoma Pathogenesis 

The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies 

Unveiling the Hidden Benefits of Lymphedema Treatment 

A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC

2.

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

3.

Massachusetts nurses with brain tumors: Department of Public Health 'in communication' with Newton-Wellesley

4.

Recent research suggests that vitamin supplements may increase the risk of developing cancer.

5.

New First-Line Option for Advanced ALK-Positive Lung Cancer

1.

Precision Oncology: Tailoring Cancer Treatment for the Individual

2.

ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer

3.

Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review

4.

A Closer Look at MCV Modules: Features, Functions, and Benefits 

5.

Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XVI

2.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot